|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000122966 |
Summary for CIT |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000122966 | Gene symbol | CIT |
| Gene name | citron rho-interacting serine/threonine kinase | |
| HGNC | 1985 | |
| Entrez ID | 11113 | |
| Gene type | protein_coding | |
| Synonyms | CIT|KIAA0949|STK21|CRIK|CITK | |
| UniProtAcc | O14578 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000122966 | CIT | DB12010 | Fostamatinib | SmallMoleculeDrug |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CIT |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CIT | 1.95e+03 | 1.08e+00 | 1.62e-01 | 6.68e+00 | 2.45e-11 | 1.78e-10 | HNSC |
| CIT | 2.06e+03 | 1.22e+00 | 1.62e-01 | 7.54e+00 | 4.58e-14 | 1.39e-12 | STAD |
| CIT | 4.99e+02 | 1.82e+00 | 5.19e-01 | 3.51e+00 | 4.42e-04 | 1.65e-03 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CIT | 6.16e+03 | 1.04e+00 | 2.67e-01 | 3.88e+00 | 1.04e-04 | 2.68e-04 | KIRC |
| CIT | 4.86e+03 | 1.13e+00 | 3.25e-01 | 3.48e+00 | 4.92e-04 | 1.15e-03 | KICH |
| CIT | 1.35e+03 | 1.96e+00 | 8.73e-02 | 2.24e+01 | 3.45e-111 | 1.72e-109 | BRCA |
Top |
Sex-biased somatic mutation for CIT |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CIT |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| GBM | cg15886307 | chr12:119877865 | CGI:chr12:119877043-119877365 | promoter | 3.13e-01 | 4.79e-01 | 3.08e+00 | 2.05e-03 | 7.47e-03 | -1.66e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg15886307 | chr12:119877865 | CGI:chr12:119877043-119877365 | promoter | 6.59e-01 | 5.54e-01 | 2.65e+00 | 8.10e-03 | 1.01e-02 | 1.05e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for CIT |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CIT |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CIT |
| TFs related to CIT. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LAML | LHX2 | CIT | 4.69e+00 | 9.82e-01 | 3.81e+00 | 1.13e-02 | Male-biased |
| LAML | NKX3-1 | CIT | 4.17e+00 | 9.80e-01 | 3.10e+00 | 5.27e-03 | Male-biased |
| SARC | BPTF | CIT | 4.16e+00 | 9.81e-01 | 3.52e+00 | 5.97e-03 | Male-biased |
| SARC | GSX1 | CIT | 4.66e+00 | 9.81e-01 | 4.14e+00 | 1.35e-02 | Male-biased |
| CIT related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CIT |
| RBPs related to ES in CIT. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LUAD | HNRNPA1L2 | exon_skip_97196 | 1.28e+01 | 9.91e-01 | 1.25e+01 | 8.64e-03 | Male-biased |
| LGG | ESRP2 | exon_skip_97203 | 6.37e+00 | 2.29e-03 | 6.85e+00 | 9.83e-01 | Female-biased |
| CIT related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000122966 | Z95331.1,hsa-mir-142,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AL031716.1,hsa-mir-142,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | ALMS1-IT1,hsa-mir-142,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | OPA1-AS1,hsa-mir-154,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC092683.1,hsa-mir-154,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | DLEU2L,hsa-mir-154,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC106037.2,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | Z95331.1,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AL022322.2,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | LINC01409,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | SLX1A-SULT1A3,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC002310.2,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC004943.2,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AP000265.1,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | BDNF-AS,hsa-mir-653,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | LINC01409,hsa-mir-653,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC138393.3,hsa-mir-653,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC092535.2,hsa-mir-653,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC010478.1,hsa-mir-653,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC109460.3,hsa-mir-653,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC020658.3,hsa-mir-873,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AL022322.2,hsa-mir-873,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | PCBP1-AS1,hsa-mir-873,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | Z97832.2,hsa-mir-873,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | C9orf163,hsa-mir-873,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC012313.3,hsa-mir-873,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC106037.2,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | Z95331.1,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | LINC01409,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AL022322.2,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC087854.1,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | SLX1A-SULT1A3,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC002310.2,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AC004943.2,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | AP000265.1,hsa-mir-93,CIT | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000122966 | OLMALINC,hsa-mir-20b,CIT | Male-specific ceRNA | TCGA-THCA |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10846567 | chr12:123875570:G:T | - | -0.053872568317109 | 0.0115537237662935 | LUAD | Female-baised eQTL |
| rs1317312 | chr12:123879584:G:C | - | -0.0532862383165272 | 0.0133771643846403 | LUAD | Female-baised eQTL |
| rs10734909 | chr12:123866485:T:C | - | -0.0523596969116773 | 0.0173652207664855 | LUAD | Female-baised eQTL |
| rs10773045 | chr12:123867119:A:G | - | -0.0523547887606148 | 0.0173838571634397 | LUAD | Female-baised eQTL |
| rs7300037 | chr12:123882530:T:C | - | -0.0516625794296189 | 0.018804770491146 | LUAD | Female-baised eQTL |
| rs7297429 | chr12:123883031:A:C | - | -0.0516625794296189 | 0.018804770491146 | LUAD | Female-baised eQTL |
| rs10773043 | chr12:123866157:T:C | - | -0.0521000544175347 | 0.0195125898753901 | LUAD | Female-baised eQTL |
| rs1882489 | chr12:123879894:T:A | - | -0.0505015855302165 | 0.0227228242036423 | LUAD | Female-baised eQTL |
| rs11057378 | chr12:123866286:C:T | - | -0.0512120647376309 | 0.0229691929802207 | LUAD | Female-baised eQTL |
| rs10773044 | chr12:123867118:G:A | - | -0.0513326820114956 | 0.0233354436912151 | LUAD | Female-baised eQTL |
| rs9669530 | chr12:123885264:C:A | - | -0.0507325859116129 | 0.023336162125686 | LUAD | Female-baised eQTL |
| rs11057383 | chr12:123884874:T:C | - | -0.0500237628312868 | 0.0236596539989927 | LUAD | Female-baised eQTL |
| rs10846566 | chr12:123868823:G:A | - | -0.050710786018159 | 0.0248076661980069 | LUAD | Female-baised eQTL |
| rs11057382 | chr12:123878342:C:T | - | -0.0501556514443554 | 0.0260381668762055 | LUAD | Female-baised eQTL |
| rs12228611 | chr12:123877514:C:T | - | -0.0499453694815961 | 0.0280274380925702 | LUAD | Female-baised eQTL |
| rs11057379 | chr12:123871110:G:A | - | -0.0497302882938699 | 0.028248041767129 | LUAD | Female-baised eQTL |
| rs117806800 | chr12:125308186:A:G | - | 0.0996634332842789 | 0.0306495539784604 | LUAD | Female-baised eQTL |
| rs12425883 | chr12:125305453:G:C | - | 0.0925770639973553 | 0.042020366122134 | LUAD | Female-baised eQTL |
| rs73233351 | chr12:125305637:G:A | - | 0.0925770639973553 | 0.042020366122134 | LUAD | Female-baised eQTL |
| rs7975979 | chr12:123866402:A:C | - | -0.0483463309269532 | 0.0426023686821633 | LUAD | Female-baised eQTL |
| rs73233352 | chr12:125305639:T:C | - | 0.0923883545883615 | 0.0426039789093343 | LUAD | Female-baised eQTL |
| rs4930727 | chr12:123864396:T:C | - | -0.0490690213241606 | 0.0431917064733222 | LUAD | Female-baised eQTL |
| rs7314963 | chr12:123865897:C:T | - | -0.0483365616562211 | 0.0434187435318836 | LUAD | Female-baised eQTL |
| rs1922258 | chr12:123869110:T:C | - | -0.0477026025426532 | 0.0466735086162587 | LUAD | Female-baised eQTL |
| rs11057381 | chr12:123873310:G:C | - | -0.0478451565658685 | 0.0470109723358618 | LUAD | Female-baised eQTL |
| rs4767836 | chr12:119641748:G:A | - | -0.0688165211843784 | 0.00111633805755349 | COAD | Female-baised eQTL |
| rs2301655 | chr12:119640772:T:C | - | -0.0666167131573439 | 0.00138723305157298 | COAD | Female-baised eQTL |
| rs1123790 | chr12:119641317:G:C | - | -0.0666167131573439 | 0.00138723305157298 | COAD | Female-baised eQTL |
| rs4767835 | chr12:119640136:G:T | - | -0.0516741644839569 | 0.0143879255796576 | COAD | Female-baised eQTL |
| rs1406452 | chr12:118884532:A:T | - | -0.0420815018840415 | 0.0227970522022191 | COAD | Female-baised eQTL |
| rs4767733 | chr12:118885190:T:A | - | -0.0420815018840415 | 0.0227970522022191 | COAD | Female-baised eQTL |
| rs2698060 | chr12:118882929:G:A | - | -0.042441691115344 | 0.0263017638141054 | COAD | Female-baised eQTL |
| rs2698061 | chr12:118883157:A:G | - | -0.042441691115344 | 0.0263017638141054 | COAD | Female-baised eQTL |
| rs2730432 | chr12:118883242:C:A | - | -0.042441691115344 | 0.0263017638141054 | COAD | Female-baised eQTL |
| rs2730434 | chr12:118881949:T:A | - | -0.0420450038046586 | 0.0315590541626256 | COAD | Female-baised eQTL |
| rs7316295 | chr12:119619615:T:C | - | -0.0474594955289869 | 0.0327952969626189 | COAD | Female-baised eQTL |
| rs1406451 | chr12:118880153:A:C | - | -0.0415653870029264 | 0.0328845627586132 | COAD | Female-baised eQTL |
| rs2698070 | chr12:118880216:G:A | - | -0.0415653870029264 | 0.0328845627586132 | COAD | Female-baised eQTL |
| rs4303287 | chr12:118880659:G:T | - | -0.0415653870029264 | 0.0328845627586132 | COAD | Female-baised eQTL |
| rs2730436 | chr12:118880872:T:C | - | -0.0415653870029264 | 0.0328845627586132 | COAD | Female-baised eQTL |
| rs2178280 | chr12:118881190:G:A | - | -0.0415653870029264 | 0.0328845627586132 | COAD | Female-baised eQTL |
| rs2178281 | chr12:118881459:C:G | - | -0.0415653870029264 | 0.0328845627586132 | COAD | Female-baised eQTL |
| rs2698055 | chr12:118881541:G:A | - | -0.0415653870029264 | 0.0328845627586132 | COAD | Female-baised eQTL |
| rs2253853 | chr12:118879859:T:A | - | -0.0411904631748819 | 0.0334335315413701 | COAD | Female-baised eQTL |
| rs11064843 | chr12:119612949:T:G | - | -0.0473989057685839 | 0.0336885288475078 | COAD | Female-baised eQTL |
| rs10774504 | chr12:119599856:G:C | - | -0.0485275545247772 | 0.0362878403988671 | COAD | Female-baised eQTL |
| rs56030803 | chr12:128701565:A:G | - | 0.0754417293321833 | 0.0403335355807806 | COAD | Female-baised eQTL |
| rs7302992 | chr12:128702884:G:T | - | 0.0754417293321833 | 0.0403335355807806 | COAD | Female-baised eQTL |
| rs10849674 | chr12:119597300:G:A | - | -0.0473752075370773 | 0.0423758572625604 | COAD | Female-baised eQTL |
| rs12579854 | chr12:119602130:G:A | - | -0.0473752075370773 | 0.0423758572625604 | COAD | Female-baised eQTL |
| rs7954674 | chr12:119602462:T:G | - | -0.0473752075370773 | 0.0423758572625604 | COAD | Female-baised eQTL |
| rs7295362 | chr12:119601897:G:C | - | -0.0471071303434607 | 0.0452897519845116 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10850802 | chr12:117229072:C:T | - | 0.0646642307048905 | 0.0123363131320055 | BLCA | Male-baised eQTL |
| rs2293045 | chr12:117224805:C:G | - | 0.0643777104672506 | 0.0133042985002005 | BLCA | Male-baised eQTL |
| rs9658490 | chr12:117232493:C:G | - | 0.062732596335636 | 0.0156854068369779 | BLCA | Male-baised eQTL |
| rs11057722 | chr12:124640528:G:A | - | 0.0537770415213126 | 0.0266203937815988 | BLCA | Male-baised eQTL |
| rs61939097 | chr12:128074970:G:A | - | 0.0899185465678055 | 0.0427039477746507 | LUAD | Male-baised eQTL |
| rs73144750 | chr12:128075058:T:C | - | 0.0899185465678055 | 0.0427039477746507 | LUAD | Male-baised eQTL |
| rs112728070 | chr12:125589413:C:T | - | 0.18234815010145 | 0.00545622406932481 | COAD | Male-baised eQTL |
| rs60311188 | chr12:125588247:A:T | - | 0.148127017337623 | 0.00814897620805559 | COAD | Male-baised eQTL |
| rs16919232 | chr12:125585265:C:G | - | 0.138292216153876 | 0.0114914017666243 | COAD | Male-baised eQTL |
| rs61944572 | chr12:124871925:A:G | - | 0.161256590977379 | 0.0267340764509988 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000122966 |
| CpG Site: cg00009001 | |
| Position to Gene: gene | |
| Male Effect: -0.275411012900647 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg00009001 | chr12:119714085 | gene | -0.275411012900647 | 7.06659968998226e-06 | -0.3312797340502919 | 2.7666380840845633e-08 | LUSC |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CIT |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000122966 | CIT | C4310723 | MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE | 1 | CTD_human |
